What to look for this week on Contemporary OB/GYN®
You can expect a variety of topics to be covered this week on Contemporary OB/GYN®, including:
The Society for Maternal-Fetal Medicine’s (SMFM) 2021 Annual Pregnancy Meeting will be held virtually throughout the month of January, with core meeting activities taking place Jan. 25-30. SMFM’s President, Judette Louis, MD, MPH, and Program Committee Chair, Cynthia Gyamfi-Bannerman, MD, MSc, tell readers what they can expect in the new online format.
January is Cervical Cancer Awareness Month. To raise awareness and spread the facts, Contemporary OB/GYN® will post a slideshow of statistics, quick facts and more each week this month.
An effective option for refractory cervical insufficiency.
Diagnosis and treatment of “the great imitator” that has resurged.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More